New predictors of response to neoadjuvant chemotherapy and survival for invasive thymoma: A retrospective analysis

Annals of Surgical Oncology

Volumn 17, Issue 11, 2010, Pages 3022-3029

  Mineo, Tommaso Claudio ^a   Mineo, Davide ^a   Onorati, Ilaria ^a   Cufari, Maria Elena ^a   Ambrogi, Vincenzo ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADJUVANT THERAPY; ADULT; ALOPECIA; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; DRUG DOSE REDUCTION; FATIGUE; FEMALE; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOPENIA; LOBAR PNEUMONIA; LUNG FIBROSIS; MALE; MEDIASTINOTOMY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MYASTHENIA; NAUSEA AND VOMITING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SIDE EFFECT; STERNOTOMY; SURGICAL TECHNIQUE; SURVIVAL TIME; THORAX SURGERY; THYMOMA; THYMOMECTOMY; THYMUS SURGERY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR NECROSIS; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYMOMA; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78049479239     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1134-9     Document Type: Article

References (28)

1. MA Jackson DL Mall 1991 Post-operative radiotherapy in invasive thymoma Radiother Oncol 21 77 82 1:STN:280:DyaK3Mzis1yrsg%3D%3D 10.1016/0167-8140(91) 90078-U 1866468
2. JF Regnard P Magdeleinat C Dromer E Dulmet V de Montpreville JF Levi, et al. 1996 Prognostic factors and long-term results after thymoma resection. A series of 307 patients J Thorac Cardiovasc Surg 112 376 384 1:STN:280: DyaK28zltVSrug%3D%3D 10.1016/S0022-5223(96)70265-9 8751506
3. M Okumura S Miyoshi Y Tacheichi HE Yoon SI Takeda Y Fujii, et al. 1999 Results of surgical treatment of thymomas with special reference to the involved organs J Thorac Cardiovasc Surg 117 605 613 1:STN:280:DyaK1M7lvV2jsQ%3D%3D 10047667
4. KB Wilkins E Sheikh R Green M Patel S George M Takano, et al. 1999 Clinical and pathologic predictors of survival in patients with thymoma Ann Surg 230 562 574 1:STN:280:DyaK1MvltVGlsw%3D%3D 10.1097/00000658-199910000-00012 10522726 (Pubitemid 30191851)
5. P Strobel A Bauer B Puppe T Kraushaar A Krein K Toyka, et al. 2004 Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis J Clin Oncol 22 1501 1509 10.1200/JCO.2004.10.113 15084623 (Pubitemid 41103633)
6. A Masaoka Y Monden K Nakahara T Tanioka 1981 Follow-up study of thymomas with special reference to their clinical stages Cancer 48 2485 2492 1:STN:280:DyaL38%2FkvVektg%3D%3D 10.1002/1097-0142(19811201)48:11<2485::AID- CNCR2820481123>3.0.CO;2-R 7296496
7. P Macchiarini A Chella F Ducci B Rossi C Testi G Bevilacqua, et al. 1991 Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma Cancer 68 706 713 1:STN:280:DyaK3MzgvFSjug%3D%3D 10.1002/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H 1855170
8. PJ Loehrer Sr M Chen K Kim SC Aisner LH Einhorn R Livingston, et al. 1997 Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial J Clin Oncol 15 3093 3099 1:CAS:528:DyaK2sXmt1Sqtr0%3D 9294472
9. DM Shin GL Walsh R Komaki JB Putnam J Nesbitt JY Ro, et al. 1998 A multidisciplinary approach to therapy for unresectable malignant thymoma Ann Intern Med 129 100 104 1:STN:280:DyaK1czhvVWrug%3D%3D 9669967
10. CS Sherr 1996 Cancer cell cycles Science 274 1672 1677 1:CAS:528:DyaK28XntlyktLs%3D 10.1126/science.274.5293.1672 8939849 (Pubitemid 26414890)
11. X Grana EP Reddy 1995 Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors Oncogene 11 211 219 1:CAS:528: DyaK2MXnt1Oqurc%3D 7624138
12. DG Kirsch MB Kastan 1998 Tumor-suppressor p53: implications for tumor development and prognosis J Clin Oncol 16 3158 3168 1:CAS:528:DyaK1cXmtFSlsbw%3D 9738588
13. V Esposito A Baldi G Tonini B Vincenzi M Santini V Ambrogi, et al. 2004 Analysis of cell-cycle regulator proteins in non-small cell lung cancer J Clin Pathol 57 58 63 1:CAS:528:DC%2BD2cXntVeksb8%3D 10.1136/jcp.57.1.58 14693837 (Pubitemid 38091312)
14. P Luna-Perez EL Arriola Y Cuadra I Alvarado A Quintero 1998 p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma Ann Surg Oncol 5 203 208 1:STN:280:DyaK1c3mvVKgtg%3D%3D 10.1007/BF02303772 9607618 (Pubitemid 28249307)
15. HG Moore J Shia DS Klimstra L Ruo M Mazumdar GK Schwartz, et al. 2004 Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome Ann Surg Oncol 11 955 961 10.1245/ASO.2004.03.095 15525823 (Pubitemid 40486660)
16. TC Mineo V Ambrogi D Mineo A Baldi 2005 Long-term disease-free survival of patients with radically resected thymomas Cancer 104 2063 2071 1:CAS:528:DC%2BD2MXht1Clu7fO 10.1002/cncr.21433 16206298 (Pubitemid 41579951)
17. G Chen A Marx C Wen-Hu J Yong B Puppe P Stroebel HK Mueller-Hermelink 2002 New WHO histologic classification predicts prognosis of thymic epithelial tumors Cancer 95 420 429 10.1002/cncr.10665 12124843 (Pubitemid 34787609)
18. K Junker M Thomas K Schulmann F Klinke U Bosse KM Müller 1997 Tumor regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment J Cancer Res Clin Oncol 123 469 477 1:STN:280: DyaK1c%2FgtFWjsQ%3D%3D 10.1007/BF01192200 9341895 (Pubitemid 27436005)
19. Rosai J, Levine GD. Tumors of the thymus. In: Atlas of tumor pathology, 2nd series, fascicle 13. Armed Forced Institute of Pathology, Washington, DC; 1976.
20. G Maggi G Giaccone M Donadio L Ciuffreda O Dalesio G Leria, et al. 1986 Thymoma: A review of 169 cases, with particular reference to results of surgical treatment Cancer 58 765 776 1:STN:280:DyaL283ntFGgtw%3D%3D 10.1002/1097- 0142(19860801)58:3<765::AID-CNCR2820580326>3.0.CO;2-S 3731027
21. G Giaccone A Ardizzoni A Kirkpatrick M Clerico T Sahmoud N van Zandwijk 1996 Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: A phase 2 study of the European Organisation for Research and Treatment of Cancer, Lung Cancer Cooperative Group J Clin Oncol 14 814 820 1:CAS:528:DyaK28Xit1GjsL8%3D 8622029
22. CR Thomas CD Wright PJ Loehrer 1999 Thymoma: state of the art J Clin Oncol 17 2280 2290 1:STN:280:DC%2BD3c%2FjtVSitg%3D%3D 10561285
23. ME Froudarakis O Tiffet P Fournel E Briasoulis V Karavasilis J Cuilleret, et al. 2001 Invasive thymoma: a clinical study of 23 cases Respiration 68 376 381 1:STN:280:DC%2BD3MvhsVOjug%3D%3D 10.1159/000050530 11464084 (Pubitemid 32678999)
24. K Kondo 2008 Optimal therapy for thymoma J Med Invest 55 17 28 10.2152/jmi.55.17 18319541 (Pubitemid 351643589)
25. K Kondo Y Monden 2003 Therapy for thymic epithelial tumors: a clinical study of 1, 320 patients from Japan Ann Thorac Surg 76 878 884 10.1016/S0003-4975(03)00555-1 12963221 (Pubitemid 37100765)
26. FC Detterbeck AM Parsons 2004 Thymic tumors Ann Thorac Surg 77 1860 1869 10.1016/j.athoracsur.2003.10.001 15111216 (Pubitemid 38530055)
27. CD Wright NC Choi JC Wain DJ Mathisen TJ Lynch P Fidias 2008 Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVa thymic tumors Ann Thorac Surg 85 385 389 10.1016/j.athoracsur.2007.08. 051 18222230
28. A Kumar SK Regmi R Dutta R Kumar SD Gupta P Das, et al. 2009 Characterization of thymic masses using (18)F-FDG PET-CT Ann Nucl Med 23 569 577 10.1007/s12149-009-0283-z 19585212